Orchestra BioMed Revenue and Competitors
Estimated Revenue & Valuation
- Orchestra BioMed's estimated annual revenue is currently $11.9M per year.
- Orchestra BioMed's estimated revenue per employee is $155,000
- Orchestra BioMed's total funding is $132.8M.
Employee Data
- Orchestra BioMed has 77 Employees.
- Orchestra BioMed grew their employee count by 8% last year.
Orchestra BioMed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Orchestra BioMed?
Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Our main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization. Orchestra BioMed’s business strategy is to leverage partnerships with established global market leaders to optimize the clinical impact and commercial value of its products. Orchestra BioMed expects to generate long-term, high margin cash flow from royalties, revenue sharing, as well as licensing and development payments from strategic partners that secure commercial rights to Orchestra BioMed-developed products. Orchestra BioMed’s core innovation and development expertise is in the areas of drug delivery, interventional devices, bioelectronics and neuromodulation
keywords:N/A
$132.8M
Total Funding
77
Number of Employees
$11.9M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Orchestra BioMed's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Product Development | Reveal Email/Phone |
2 | Senior Director Marketing | Reveal Email/Phone |
3 | SVP, Medical Affairs and Innovation | Reveal Email/Phone |
4 | Principal Scientist | Reveal Email/Phone |
5 | VP Human Resources | Reveal Email/Phone |
6 | VP Regulatory Affairs | Reveal Email/Phone |
7 | Director, Analytical Operations | Reveal Email/Phone |
8 | Corporate Controller | Reveal Email/Phone |
9 | Senior Accountant | Reveal Email/Phone |
10 | Principle R&D Engineer | Reveal Email/Phone |
Orchestra BioMed News
She will study biomedical sciences at Ohio State. ... orchestra, chamber orchestra, Key Club, Eco Club and the Biomed Program.
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc., a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, today announced that it has entered into a $20 million credit facility agreement with Silicon Valley Bank (SVB), ...
NEW HOPE, Pa., July 10, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc., a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, today announced it has completed a $34 million Series B-1 Preferred Stock financing led by institutional inv ...
Hot on the heels of inking an international distribution deal with Terumo, Orchestra BioMed has secured $34 million in new funding for its devices aimed at high blood pressure and blocked arteries. Sponsored by Agilent Technologies How would you like to win free bench space at Lab Central for ...
Other Companies in New Hope
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23.5M | 81 | 5% | N/A |
#2 | $23.5M | 81 | 11% | N/A |
#3 | $23M | 85 | 5% | N/A |
#4 | $18.1M | 86 | 19% | N/A |
#5 | $29.7M | 90 | 3% | N/A |